Turner R, Tjian R
Howard Hughes Medical Institute, Department of Biochemistry, University of California, Berkeley 94720.
Science. 1989 Mar 31;243(4899):1689-94. doi: 10.1126/science.2494701.
The discovery that the AP-1 family of enhancer binding factors includes a complex of the cellular Fos (cFos) and cellular Jun (cJun) proteins established a direct and important link between oncogenesis and transcriptional regulation. Homodimeric cJun protein synthesized in vitro is capable of binding selectively to AP-1 recognition sites, whereas the cFos polypeptide is not. When cotranslated, the cFos and cJun proteins can form a stable, heterodimeric complex with the DNA binding properties of AP-1/cJun. The related proteins Jun B and vJun are also able to form DNA binding complexes with cFos. Directed mutagenesis of the cFos protein reveals that a leucine repeat structure is required for binding to cJun, in a manner consistent with the proposed function of the "leucine zipper." A novel domain adjacent to, but distinct from, the leucine repeat of cFos is required for DNA binding by cFos-cJun heterodimers. Thus experimental evidence is presented that leucine repeats can mediate complex formation between heterologous proteins and that promotes further understanding of the molecular mechanisms underlying the function of two proto-oncogene products.
增强子结合因子AP-1家族包含细胞Fos(cFos)和细胞Jun(cJun)蛋白复合物这一发现,在肿瘤发生与转录调控之间建立了直接且重要的联系。体外合成的同二聚体cJun蛋白能够选择性地结合AP-1识别位点,而cFos多肽则不能。当共同翻译时,cFos和cJun蛋白可以形成具有AP-1/cJun DNA结合特性的稳定异二聚体复合物。相关蛋白Jun B和vJun也能够与cFos形成DNA结合复合物。对cFos蛋白进行定向诱变表明,与“亮氨酸拉链”的拟功能一致地,结合cJun需要亮氨酸重复结构。cFos-cJun异二聚体进行DNA结合需要一个与cFos亮氨酸重复相邻但不同的新结构域。因此,有实验证据表明亮氨酸重复可以介导异源蛋白之间的复合物形成,这有助于进一步理解两种原癌基因产物功能背后的分子机制。